158 related articles for article (PubMed ID: 33221024)
1. Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.
Rodriguez AM; Polychronopoulou E; Hsu E; Shah R; Lamiman K; Kuo YF
Gynecol Oncol; 2021 Jan; 160(1):16-23. PubMed ID: 33221024
[TBL] [Abstract][Full Text] [Related]
2. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia.
Matsuo K; Ramzan AA; Gualtieri MR; Mhawech-Fauceglia P; Machida H; Moeini A; Dancz CE; Ueda Y; Roman LD
Gynecol Oncol; 2015 Nov; 139(2):261-7. PubMed ID: 26238457
[TBL] [Abstract][Full Text] [Related]
3. Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women.
Rodriguez AM; Schmeler KM; Kuo YF
Gynecol Oncol; 2014 Dec; 135(3):525-33. PubMed ID: 25449307
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling.
Rotenberg O; Doulaveris G; Fridman D; Renz M; Kaplan J; Xie X; Goldberg GL; Dar P
Am J Obstet Gynecol; 2020 Dec; 223(6):896.e1-896.e7. PubMed ID: 32640199
[TBL] [Abstract][Full Text] [Related]
5. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
6. Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding.
Anastasiadis PG; Skaphida PG; Koutlaki NG; Galazios GC; Tsikouras PN; Liberis VA
Eur J Gynaecol Oncol; 2000; 21(2):131-4. PubMed ID: 10843470
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women.
Viola AS; Gouveia D; Andrade L; Aldrighi JM; Viola CF; Bahamondes L
Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):207-13. PubMed ID: 18366497
[TBL] [Abstract][Full Text] [Related]
8. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
[TBL] [Abstract][Full Text] [Related]
9. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
11. Endometrial hyperplasia and endometrial cancer.
Burke TW; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
Obstet Gynecol Clin North Am; 1996 Jun; 23(2):411-56. PubMed ID: 8784886
[TBL] [Abstract][Full Text] [Related]
12. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.
Hunter JE; Tritz DE; Howell MG; DePriest PD; Gallion HH; Andrews SJ; Buckley SB; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1994 Oct; 55(1):66-71. PubMed ID: 7959270
[TBL] [Abstract][Full Text] [Related]
13. Threshold for endometrial sampling among postmenopausal patients without vaginal bleeding.
Louie M; Canavan TP; Mansuria S
Int J Gynaecol Obstet; 2016 Mar; 132(3):314-7. PubMed ID: 26658096
[TBL] [Abstract][Full Text] [Related]
14. Recent racial/ethnic disparities in stroke hospitalizations and outcomes for young adults in Florida, 2001-2006.
Pathak EB; Sloan MA
Neuroepidemiology; 2009; 32(4):302-11. PubMed ID: 19287184
[TBL] [Abstract][Full Text] [Related]
15. Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy.
Reed SD; Newton KM; Garcia RL; Allison KH; Voigt LF; Jordan CD; Epplein M; Swisher E; Upson K; Ehrlich KJ; Weiss NS
Obstet Gynecol; 2010 Aug; 116(2 Pt 1):365-373. PubMed ID: 20664397
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites.
Cook LS; Nelson HE; Cockburn M; Olson SH; Muller CY; Wiggins CL
Cancer Causes Control; 2013 Jan; 24(1):61-9. PubMed ID: 23109171
[TBL] [Abstract][Full Text] [Related]
17. Impact of hysterectomy on endometrial carcinoma rates in the United States.
Sherman ME; Carreon JD; Lacey JV; Devesa SS
J Natl Cancer Inst; 2005 Nov; 97(22):1700-2. PubMed ID: 16288124
[TBL] [Abstract][Full Text] [Related]
18. Relation of metabolic syndrome with endometrial pathologies in patients with abnormal uterine bleeding.
Özdemir S; Batmaz G; Ates S; Celik C; Incesu F; Peru C
Gynecol Endocrinol; 2015; 31(9):725-9. PubMed ID: 26182187
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of endometrial cancer in patients with biopsy specimens of endometrial hyperplasia].
Zeferino-Toquero M; Bañuelos-Flores J; Maytorena-Córdova G; Reyna-Amaya H; Acevedo-Vega MF
Ginecol Obstet Mex; 2013 Sep; 81(9):519-24. PubMed ID: 24187815
[TBL] [Abstract][Full Text] [Related]
20. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
Ko EM; Walter P; Clark L; Jackson A; Franasiak J; Bolac C; Havrilesky L; Secord AA; Moore DT; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2014 Apr; 133(1):28-32. PubMed ID: 24680588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
